Focus Partners Wealth’s AbbVie ABBV Stock Holding History

Focus Partners Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$194M	Sell	894,467 -17,893	-2%	-$3.97M	0.22%	103
2025 Q4	$208M	Buy	912,360 +262,552	+40%	+$59.8M	0.24%	89
2025 Q3	$150M	Buy	649,808 +20,297	+3%	+$4.13M	0.24%	79
2025 Q2	$108M	Buy	629,511 +91,292	+17%	+$17M	0.23%	88
2025 Q1	$113M	Buy	538,219 +8,629	+2%	+$1.68M	0.28%	73
2024 Q4	$94.1M	Buy	529,590 +99,181	+23%	+$18.2M	0.24%	86
2024 Q3	$84.9M	Buy	430,409 +76,445	+22%	+$14.3M	0.27%	80
2024 Q2	$60.7M	Buy	353,964 +135,556	+62%	+$22.5M	0.2%	114
2024 Q1	$39.8M	Buy	218,408 +63,664	+41%	+$11M	0.32%	74
2023 Q4	$24M	Buy	+154,744	New	+$22.6M	0.31%	86

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Focus Partners Wealth's ABBV Position: Q1 2026 in Review

Focus Partners Wealth reduced its AbbVie (ABBV) stake by 2% in Q1 2026, selling an estimated $3.97M and leaving 894,467 shares worth $194M. The position accounts for 0.22% of the portfolio, ranked #103.

Focus Partners Wealth first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $208M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Focus Partners Wealth held 894,467 shares of AbbVie worth $194M as of Q1 2026.
Focus Partners Wealth sold 17,893 AbbVie shares in Q1 2026, an estimated $3.97M.
AbbVie made up 0.22% of Focus Partners Wealth's portfolio in Q1 2026, its #103 holding.
Focus Partners Wealth first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Focus Partners Wealth's AbbVie position peaked at $208M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.